Drugs / Chlorotoxin-CD28-CD3z-CD19t-expressing CAR T-cells
Chlorotoxin-CD28-CD3z-CD19t-expressing CAR T-cells
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT04214392 | Feb 2020 → May 2027 expected | glioblastoma, grade II glioma, grade III glioma | City of Hope Medical Center | Active not recruiting | No outcome recorded |
Evidence & citations 4 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Chlorotoxin-CD28-CD3z-CD19t-expressing CAR T-cells | “Chlorotoxin-CD28-CD3z-CD19t-expressing CAR T-cells” NCT04214392 ↗ |
| Action | Deplete | “kill tumor cells” NCT04214392 ↗ |
| Modality | Cell therapy | “chimeric antigen receptor (CAR) T cells with a chlorotoxin tumor-targeting domain” NCT04214392 ↗ |
| Route | Other | “Given via ICT delivery” NCT04214392 ↗ |